Hexolame
Hexolame is an estrogen receptors agonist with dual anticoagulant and estrogenic properties. Hexolame binds to estrogen receptors to induce anticoagulant effects by modulating clotting factors or platelet activity. Hexolame is promising for research of prostatic cancer and prevention of thrombosis[1].
Product Specifications
CAS Number
110346-23-1
UNSPSC
12352211
Target
Estrogen Receptor/ERR
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Smiles
C[C@@]12[C@](CC[C@@H]2NCCCCCCO)([H])[C@@]3([H])[C@@](CC1)([H])C4=CC=C(O)C=C4CC3
Molecular Formula
C24H37NO2
Molecular Weight
371.56
References & Citations
[1]Rubio-Póo C, et al. The anticoagulant effect of hexolame, N- (3-hydroxy-1,3,5 (10) -estratrien-17 beta-yl) -6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect. Steroids. 1990 Feb;55 (2) :83-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
